The fight against cancer will involve understanding its complexities. Developing technologies to under-studied analytes of cancer will be integral to this process. The adoption of the described tumor specimen processing approach in primary bladder cancer in this study represents a novel means for biobanks to generate and collect dedicated aliquots for research into these analytes of increasing importance.
Mojica et al. (Fri,) studied this question.